Global Finance

APRIL 5, 2025

Market participants entered the year hoping for a robust revival in M&A, IPO, and debt financing activities. Despite indicators that 2025 could bring a sharper rebound in M&A activity, many of the headwinds that curtailed growth in recent years arent abating. That should change in 2025, Van Oostende says.

Banking

Business Wire M&A

JULY 8, 2025

MONTREAL--(BUSINESS WIRE)--Birks Group Inc.

Debt Financing

Benzinga

JUNE 10, 2025

June 10, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. As consideration for the transaction, Windtree will issue preferred shares and has secured debt financing to fund the transaction and working capital for the business.

Debt Financing

Business Wire M&A

JULY 21, 2025

AUSTIN, Texas--(BUSINESS WIRE)-- #acquisitions--Mercom Capital Group, a global clean energy communications and consulting firm, released its report on funding and merger and acquisition (M&A) activity for the solar sector in the second quarter (Q2) and first half (1H) of 2025. billion, 39% lower year-over-year (YoY) compared to $17.6

Debt Financing

Scott Mashuda

OCTOBER 10, 2024

This increased liquidity, coupled with easing interest rates, makes financing more accessible and affordable for lower middle market companies, which often rely heavily on debt financing. With potential rate environment uncertainties looming by mid-2025, swift, strategic action and expert advisory support are imperative.

Finance

Benzinga

SEPTEMBER 26, 2023

Product delivery is scheduled for the first quarter of 2024 with revenue totaling approximately $30 Million for the first twelve months of production and subsequent revenue of over $45 Million per year beginning in 2025, and continuing through 2033. 26, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc.

Debt Financing

Benzinga

AUGUST 22, 2024

Cyclo Therapeutics' TransportNPC™ Phase 3 clinical trial for Trappsol ® Cyclo™ for the treatment of Niemann-Pick Disease Type C1, a rare and fatal genetic disease, is fully enrolled and results from the 48-week interim analysis are expected in the middle of 2025 NEWARK, N.J. and GAINESVILLE, Fla.,

Debt Financing

Benzinga

OCTOBER 21, 2024

The transaction is expected to close in early 2025, subject to customary closing conditions. and UBS Investment Bank are acting as financial advisors and providing debt financing for the transaction. Secureworks shareholders, including Dell Technologies (NYSE: DELL ), will receive $8.50 per share in cash.

Technology

Benzinga

JUNE 23, 2022

Debt financing for this transaction will be provided by OrbiMed Advisors, LLC. sales and Japan royalties or supply payments based on supply of TYMLOS for sale in Japan) during any consecutive 12-month period prior to December 31, 2025. per share in cash plus a CVR of $1.00 per share in cash plus a CVR of $1.00

Debt Financing

Reynolds Holding

JUNE 13, 2024

Thank you for inviting me to testify today on the Securities and Exchange Commission’s Fiscal Year (FY) 2025 budget request. debt capital markets facilitate 75 percent of debt financing of non-financial corporations. Furthermore, the SEC announced it will close our Salt Lake City office early in FY 2025.

Technology

Benzinga

AUGUST 1, 2024

Transaction Details: Total estimated consideration for the Teads acquisition is approximately $1 billion, on a cash free, debt free basis, including an upfront payment of $725 million, subject to standard adjustments, and a deferred cash payment of $25 million. subject to customary funding conditions.

Debt Financing

Reynolds Holding

NOVEMBER 13, 2024

The regulations’ prohibitions and reporting requirements go into effect on January 2, 2025. Beginning on January 2, 2025, some “covered transactions” will be prohibited outright, while others will require post-transaction notification to the newly created Office of Global Transactions within the U.S. investment fund (31 C.F.R.

Treasury

Reynolds Holding

DECEMBER 5, 2024

The Outbound Rules will take effect on January 2, 2025, and will add a new layer of diligence to most U.S. making a loan or providing other debt financing that is either convertible or affords the right to be involved in the target’s management in certain capacities; 3. investment. See our prior mailers here and here.

Treasury

Cooley M&A

FEBRUARY 14, 2025

Download the report Whats covered inside: Key PE moves witnessed in 2024 and where deals got done The new administration and what to expect from potential policy changes Where regulatory watchdogs sharpened their focus Ways PE is deploying artificial intelligence technology How market conditions shaped debt financing Uptiering as a liability management (..)

Equity

Benzinga

APRIL 9, 2025

million cash each within nine months and 18 months from the closing.

Debt Financing

Benzinga

MAY 27, 2025

The combined company will continue to have no outstanding debt for borrowed money after this financing. Strive CEO Matt Cole to discuss the company's proposed alpha-generating Bitcoin strategies during his 11:54 AM PT keynote on May 27, 2025 at the Bitcoin for Corporations Symposium in Las Vegas, Nevada.

Alpha

Benzinga

MAY 21, 2025

BOSTON, May 21, 2025 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc., Optinose shareholders approved the merger proposal at Optinose's special meeting of shareholders held on May 16, 2025, and following completion of the merger Optinose's common stock will be delisted from the Nasdaq Global Select Market.

Debt Financing

Benzinga

MARCH 4, 2025

March 04, 2025 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. This transaction, which closed on March 3, 2025, marks a significant milestone in Star's growth strategy. Transaction Highlights Transaction values ADT at a cash-free, debt-free enterprise value of $12.65 OLD GREENWICH, Conn., million, funded in part by $2.5

Equity

Benzinga

MAY 20, 2025

. - Highly unique Helium asset is expected to benefit from $750 million of committed debt funding from the U.S. government's development finance institution and other lenders to expand plant production capacity in South Africa. The webcast can be accessed here: [link] WASHINGTON, May 20, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc.

EBITDA

Benzinga

MARCH 19, 2025

March 19, 2025 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals and Optinose, Inc. The upfront consideration of $9 per share represents a 50% premium to Optinose's closing trading price on March 19, 2025. The Boards of both Paratek and Optinose have unanimously approved the transaction.

Debt Financing

Benzinga

FEBRUARY 3, 2025

03, 2025 (GLOBE NEWSWIRE) -- Outbrain Inc. million shares of common stock of Outbrain (valued at approximately $263 million based on the closing price of Outbrain's common stock as of January 31, 2025, of $6.01). The replay will be available until February 17, 2025. NEW YORK, Feb. subject to customary funding conditions.

EBITDA

Cooley M&A

FEBRUARY 3, 2025

Over the course of the year, many of the headwinds that have slowed tech M&A activity since 2022 began to abate as interest rates moderated, the acquisition financing market returned and equity markets reached new highs. Lets take a closer look at key developments in tech M&A during 2024 and what we could see in 2025.

Equity